Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
10.77
-0.14 (-1.33%)
At close: Mar 9, 2026, 4:00 PM EDT
11.09
+0.32 (3.02%)
After-hours: Mar 9, 2026, 5:20 PM EDT
Rallybio Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 57 | 40 | 90 | 249 | 307 | - | |
| Market Cap Growth | 78.23% | -55.91% | -63.67% | -18.90% | - | - | |
| Enterprise Value | -2 | -35 | -31 | 117 | 120 | - | |
| Last Close Price | 10.91 | 7.68 | 19.12 | 52.56 | 76.32 | - | |
| PS Ratio | 84.13 | 62.62 | - | - | - | - | |
| PB Ratio | 0.91 | 0.65 | 0.85 | 1.47 | 1.75 | - | |
| P/TBV Ratio | 0.90 | 0.65 | 0.85 | 1.47 | 1.75 | - | |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | - | - | |
| Net Debt / Equity Ratio | -0.94 | -1.06 | -1.03 | -0.99 | -1.00 | -1.03 | |
| Net Debt / EBITDA Ratio | 1.78 | 1.15 | 1.39 | 2.49 | 3.85 | 5.56 | |
| Net Debt / FCF Ratio | 1.69 | 1.33 | 1.82 | 2.94 | 3.82 | 6.32 | |
| Asset Turnover | 0.01 | 0.01 | - | - | - | - | |
| Quick Ratio | 13.13 | 10.50 | 11.87 | 15.73 | 26.76 | 24.00 | |
| Current Ratio | 14.74 | 10.87 | 12.39 | 16.71 | 27.61 | 24.18 | |
| Return on Equity (ROE) | -21.17% | -68.85% | -54.13% | -38.65% | -30.18% | -34.60% | |
| Return on Assets (ROA) | -28.35% | -38.91% | -33.33% | -23.40% | -17.61% | -19.35% | |
| Return on Capital Employed (ROCE) | -52.70% | -92.50% | -74.20% | -40.00% | -26.00% | -18.60% | |
| Earnings Yield | -24.99% | -145.06% | -82.55% | -26.81% | -15.34% | - | |
| FCF Yield | -61.72% | -123.74% | -66.73% | -23.06% | -14.96% | - | |
| Buyback Yield / Dilution | -5.40% | -7.66% | -27.11% | -24.70% | -46.76% | -913.79% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.